How many institutions held FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in Q1 2016?

42 institutional investors reported FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share for Q1 2016. Use the holders table for investor-level position and value details.

FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q: What does CUSIP 31189P102 represent in this 13F holders report?

CUSIP 31189P102 is the security identifier for FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 31189P102

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 122,342,805
Total 13F shares: 15,773,542
Share change: -2,834,554
Total reported value: $28,394,000
Price per share: $1.80
Number of holders: 42
Value change: -$9,461,086
Number of buys: 21
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 31189P102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	3.5%	4,307,485	$14,516,000	—	31 Dec 2015	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	2.1%	2,596,489	$8,750,000	—	31 Dec 2015	13F
Polaris Venture Management Co. V, L.L.C.	13F	Company	2%	2,473,186	$8,335,000	—	31 Dec 2015	13F
Redmile Group, LLC	13F	Company	1.9%	2,371,001	$7,990,000	—	31 Dec 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.1%	1,306,569	$4,403,000	—	31 Dec 2015	13F
Broadfin Capital, LLC	13F	Company	0.91%	1,113,986	$3,754,000	—	31 Dec 2015	13F
ORBIMED ADVISORS LLC	13F	Company	0.57%	692,900	$2,335,000	—	31 Dec 2015	13F
FRANKLIN RESOURCES INC	13F	Company	0.41%	500,000	$1,685,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	0.34%	415,243	$1,399,000	—	31 Dec 2015	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.29%	350,800	$1,182,000	—	31 Dec 2015	13F
Lombard Odier Asset Management (USA) Corp	13F	Company	0.29%	350,306	$1,181,000	—	31 Dec 2015	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.24%	291,067	$981,000	—	31 Dec 2015	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	224,537	$757,000	—	31 Dec 2015	13F
Allianz Asset Management GmbH	13F	Company	0.17%	209,307	$705,000	—	31 Dec 2015	13F
Alyeska Investment Group, L.P.	13F	Company	0.14%	168,881	$569,000	—	31 Dec 2015	13F
Belmont Global Advisors, Inc.	13F	Company	0.13%	165,000	$556,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.09%	108,093	$364,000	—	31 Dec 2015	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.08%	100,000	$337,000	—	31 Dec 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	95,230	$321,000	—	31 Dec 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.07%	88,500	$298,000	—	31 Dec 2015	13F
Telemetry Investments, L.L.C.	13F	Company	0.06%	69,993	$236,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	0.05%	64,611	$218,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	0.05%	63,428	$213,000	—	31 Dec 2015	13F
Spark Investment Management LLC	13F	Company	0.05%	62,600	$210,000	—	31 Dec 2015	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	51,745	$173,000	—	31 Dec 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.04%	49,795	$167,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.03%	41,816	$141,000	—	31 Dec 2015	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.03%	37,253	$126,000	—	31 Dec 2015	13F
TFS CAPITAL LLC	13F	Company	0.03%	32,495	$110,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	26,691	$90,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.02%	25,531	$86,000	—	31 Dec 2015	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	19,946	$67,000	—	31 Dec 2015	13F
Hochman Cole Investment Advisors, Inc.	13F	Company	0.01%	16,341	$55,000	—	31 Dec 2015	13F
Virtu KCG Holdings LLC	13F	Company	0.01%	15,057	$51,000	—	31 Dec 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	14,464	$49,000	—	31 Dec 2015	13F
NOMURA HOLDINGS INC	13F	Company	0.01%	13,000	$44,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	12,880	$43,000	—	31 Dec 2015	13F
Tufton Capital Management	13F	Company	0.01%	11,858	$40,000	—	31 Dec 2015	13F
Walleye Trading LLC	13F	Company	0.01%	10,300	$35,000	—	31 Dec 2015	13F
Creative Planning	13F	Company	0.01%	7,000	$24,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	6,470	$21,000	—	31 Dec 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	5,699	$19,000	—	31 Dec 2015	13F
IFP Advisors, Inc	13F	Company	0%	5,200	$18,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	0%	5,000	$17,000	—	31 Dec 2015	13F
BlackRock Investment Management, LLC	13F	Company	0%	4,327	$15,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0%	4,230	$14,000	—	31 Dec 2015	13F
BlackRock Japan Co. Ltd	13F	Company	0%	3,948	$13,000	—	31 Dec 2015	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0%	1,038	$3,000	—	31 Dec 2015	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0%	1,000	$3,000	—	31 Dec 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,000	$3,000	—	31 Dec 2015	13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2016

As of 31 Mar 2016, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,773,542 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Belmont Global Advisors, Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, and PRINCIPAL FINANCIAL GROUP INC. This page lists 42 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

Q1 2016 holders

Holder diff

-9

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.